Part I: Not all DCIS is "Risky"

Ductal carcinoma in situ (DCIS) is considered the earliest form of breast cancer and noninvasive, meaning it hasn't spread out of the milk duct and has a low risk of becoming invasive. In part 1 of the DCIS webinar series, you will learn about different types and grades of DCIS and why that is important. The grade of a cancer describes how the cells look and how quickly they grow compared with normal cells. It also indicates how likely it is to develop into an invasive cancer. There is no one-size-fits-all treatment plan for DCIS.
Our speaker, Deborah Collyar, a DCIS survivor, author, and President of Patient Advocates In Research (PAIR) will discuss the specific factors needed as you consider treatment options vs active monitoring.
For more information about SHARE, visit our website at sharecancersupport.org or call our Helpline at 844.ASK.SHARE (844.275.7427).